Position in LLY
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$55,591,818
-$7,688,570 QoQ
Shares Held
60,441
+2.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $434,660,167 across 16 Drug Manufacturers - General names. LLY ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
243,853 | $85,799,678 | |
| 2 | NVS |
Novartis AG
|
403,774 | $61,676,478 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
60,441 | $55,591,818 | |
| 4 | AZN |
Astrazeneca PLC
|
191,107 | $37,690,122 | |
| 5 | JNJ |
Johnson & Johnson
|
139,822 | $34,178,089 | |
| 6 | MRK |
Merck & Co., Inc.
|
232,295 | $27,942,765 | |
| 7 | GSK |
GSK plc
|
480,636 | $26,526,300 | |
| 8 | SNY |
Sanofi
|
509,464 | $24,545,975 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,591,818 | 60,441 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $63,280,388 | 58,883 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $42,239,680 | 55,360 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $40,705,497 | 52,218 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $37,147,779 | 44,978 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $32,883,340 | 42,595 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $44,042,735 | 49,713 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $41,933,580 | 46,316 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,421,939 | 42,961 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $23,548,802 | 40,398 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $21,112,431 | 39,306 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $18,392,457 | 39,218 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,449,396 | 42,075 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $14,132,399 | 38,630 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $61,197,221 | 189,260 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $56,021,432 | 172,783 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $47,500,764 | 165,872 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $43,923,123 | 159,015 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $35,299,819 | 152,780 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $33,862,233 | 147,535 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $61,804,539 | 330,824 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $116,263,899 | 688,604 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $91,968,970 | 621,328 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $86,067,753 | 524,228 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $65,299,804 | 470,731 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||